Advertisement

Topics

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Multiple Myeloma, Date of authorisation: 16/03/2016, Revision: 4, Status: Authorised

12:00 EDT 16 Apr 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Multiple Myeloma, Date of authorisation: 16/03/2016, Revision: 4, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Multiple Myeloma, Date of authorisation: 16/03/2016, Revision: 4, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Neofordex, dexamethasone, Multiple Myeloma, Date of authorisation: 16/03/2016, Revision: 4, Status: Authorised"

Advertisement
Quick Search
Advertisement
Advertisement